Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Microbot Medical ( (MBOT) ) has shared an update.
On February 11, 2025, Microbot Medical Inc. announced the closing of a $13 million registered direct offering and a concurrent private placement. The funds raised will support the development and commercialization of the LIBERTY® Robotic System, as well as the expansion of applications from the company’s IP portfolio, which could enhance its market position in the medical technology field.
More about Microbot Medical
Microbot Medical Inc. is a clinical stage medical technology company that aims to improve the quality of care for patients and providers globally. The company has developed the world’s first single-use, fully disposable endovascular robotic system, designed to overcome traditional barriers to advanced robotic systems.
YTD Price Performance: 78.07%
Average Trading Volume: 3,623,276
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $66.16M
Find detailed analytics on MBOT stock on TipRanks’ Stock Analysis page.
